Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inés Moret

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Inflammatory Bowel Diseases|July 29, 2009
Mitochondrial dysfunction, persistent oxidative damage, and catalase inhibition in immune cells of naïve and treated Crohn's diseaseBelén Beltrán, Pilar Nos, Francisco Dasí, et al.
Biomedicines|November 27, 2025
Cytokine Dynamics During Ustekinumab Induction as Predictors of Treatment Response in Crohn's Disease: An Observational StudyAlejandro Mínguez, Beatriz Mateos, Marisa Iborra, et al.
Clinical and Translational Gastroenterology|October 25, 2021
Specific Plasma MicroRNA Signatures in Predicting and Confirming Crohn's Disease Recurrence: Role and Pathogenic ImplicationsInés Moret-Tatay, Elena Cerrillo, David Hervás, et al.
Clinical and Translational Gastroenterology|October 31, 2019
Identification of Epigenetic Methylation Signatures With Clinical Value in Crohn's DiseaseInés Moret-Tatay, Elena Cerrillo, Esteban Sáez-González, et al.
Journal of Clinical Apheresis|May 10, 2017
Adsorptive granulocyte/monocyte apheresis use in severe ulcerative colitis and determination of changes in plasma cytokinesBelén Beltrán, Esteban Sáez-González, Inés Moret, et al.
Human Reproduction Open|December 16, 2022
Human umbilical cord platelet-rich plasma to treat endometrial pathologies: methodology, composition and pre-clinical modelsAdolfo Rodríguez-Eguren, Lucía de Miguel-Gómez, Emilio Francés-Herrero, et al.
Digestive Diseases (Basel, Switzerland)|August 28, 2018
Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's DiseaseBelén Beltrán, Marisa Iborra, Esteban Sáez-González, et al.
International Journal of Molecular Sciences|December 23, 2022
The Genetic Diversity and Dysfunctionality of Catalase Associated with a Worse Outcome in Crohn's DiseaseMarisa Iborra, Inés Moret, Enrique Busó, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Inflammatory Bowel Diseases|July 29, 2009
Mitochondrial dysfunction, persistent oxidative damage, and catalase inhibition in immune cells of naïve and treated Crohn's diseaseBelén Beltrán, Pilar Nos, Francisco Dasí, et al.
Biomedicines|November 27, 2025
Cytokine Dynamics During Ustekinumab Induction as Predictors of Treatment Response in Crohn's Disease: An Observational StudyAlejandro Mínguez, Beatriz Mateos, Marisa Iborra, et al.
Clinical and Translational Gastroenterology|October 25, 2021
Specific Plasma MicroRNA Signatures in Predicting and Confirming Crohn's Disease Recurrence: Role and Pathogenic ImplicationsInés Moret-Tatay, Elena Cerrillo, David Hervás, et al.
Clinical and Translational Gastroenterology|October 31, 2019
Identification of Epigenetic Methylation Signatures With Clinical Value in Crohn's DiseaseInés Moret-Tatay, Elena Cerrillo, Esteban Sáez-González, et al.
Journal of Clinical Apheresis|May 10, 2017
Adsorptive granulocyte/monocyte apheresis use in severe ulcerative colitis and determination of changes in plasma cytokinesBelén Beltrán, Esteban Sáez-González, Inés Moret, et al.
Human Reproduction Open|December 16, 2022
Human umbilical cord platelet-rich plasma to treat endometrial pathologies: methodology, composition and pre-clinical modelsAdolfo Rodríguez-Eguren, Lucía de Miguel-Gómez, Emilio Francés-Herrero, et al.
Digestive Diseases (Basel, Switzerland)|August 28, 2018
Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's DiseaseBelén Beltrán, Marisa Iborra, Esteban Sáez-González, et al.
International Journal of Molecular Sciences|December 23, 2022
The Genetic Diversity and Dysfunctionality of Catalase Associated with a Worse Outcome in Crohn's DiseaseMarisa Iborra, Inés Moret, Enrique Busó, et al.
Pageof 3